Offerings

Gather-ed addresses the challenges of traditional health professional educational models through a focus on collaborative, peer-based, efficient educational process delivering formative and enjoyable learning experiences. Check out our current offerings! 

Treatment of Early-Stage Non-Small Cell Lung Cancer

Immunotherapy, which has demonstrated benefits in advanced and metastatic settings, is moving into early non-small cell lung cancer treatment, expanding options for patients with resected or resectable early-stage non-small cell lung cancer. This rapid evolution of the early NSCLC treatment...

Optimizing Treatment for Patients with CLL

Chronic lymphocytic leukemia (CLL) is the most common form of leukemia in Western countries, with an age-adjusted incidence of 4.6 per 100,000 individuals per year. As small lymphocytic lymphoma (SLL) refers to the same malignant process with primary nodal involvement rather than blood, these are...

New Opportunities in the Care of Patients with Duchenne Muscular Dystrophy

The goal of this initiative is to improve the care of patients with Duchenne muscular dystrophy (DMD). DMD is the most common childhood form of muscular dystrophy and characteristic manifestations are progressive muscle weakness, cardiorespiratory impairment, and premature death. Gene therapy...

Striking a Balance: Understanding Pain Management and Opioids

Striking a Balance: Understanding Pain Management and Opioids, thoughtfully balances the risks and benefits of safe opioid prescribing. It covers: effective patient assessment, creating patient-centered pain treatment plans, non-pharmaceutical pain treatment options, managing patients on opioid...

Unlocking The Potential Of Breakthroughs In NSCLC Therapeutic Approaches

The proposed activities will inform clinicians of recent evidence from clinical trials on the efficacy and safety of TROP2-directed antibody-drug conjugates (ADCs) in patients with progressive NSCLC, allowing them to quickly integrate new treatments into their practice when they become available....

Relief In Sight – Understanding The Burden Of Spondyloarthritis

This interactive online activity uses self-study and group discussion modules on a collaborative platform to examine various facets about spondyloarthritis (SpA) conditions. Learn more about differentiating SpA for a timely diagnosis and targeted treatments including IL-17 antagonists, as well as...

Managing Prurigo Nodularis – Latest Advances And Strategies

Considering the significant impact Prurigo Nodularis (PN) has on patients’ quality of life, it is critical for patients to receive a timely diagnosis and oftentimes can be difficult to treat. Furthermore, understanding the underlying pathogenesis is important to determine the optimal treatment...

Unlocking the Complex Management of Short Bowel Syndrome

Surgical removal of parts of the small intestine can lead to short bowel syndrome (SBS), causing disruptions in electrolyte balance, fluid absorption, and nutrition. Explore the management of SBS symptoms and strategies for enhancing intestinal adaptation to help patients reach the goal of enteral...

New Perspectives in the Front-line Treatment of Metastatic Bladder Cancer

Advanced and metastatic urothelial carcinoma (a/mUC) of the bladder comprises a small subset of all urothelial tumors but accounts for the majority of the rapid mortality associated with this disease. Over the last decade, accelerating basic science research has enabled a deeper understanding of...

Assessing and Managing IBS-C

Learn the best practice guidelines for diagnosing and treating IBS-C and how to effectively communicate with patients with IBS to improve clinical outcomes and increase patient and provider satisfaction.

The Multiple Myeloma Patient Journey

Multiple myeloma is the second-most-common hematologic malignancy in the United States with approximately 34,470 new cases diagnosed in the United States in 2022. Although multiple myeloma is an incurable disease, numerous active agents are available that, when used in combination, often lead to...

How MS Care Has Evolved Since the COVID-19 Pandemic

As a result of the COVID-19 pandemic, we have learned valuable lessons pertinent to MS care. This includes knowledge about COVID-19 severity and infection risk (especially as it relates to DMT selection), a much greater understanding of how DMTs affect SARS-CoV-2 vaccine responses, ways to...

Turning Complexity into Clarity in Chronic Immune-Mediated Neuropathies

Often seen in Guillain–Barré syndrome (GBS), chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN), arise as a consequence of immune system involvement and can have myriad health consequences. Both CIDP and MMN are characterized by complex presentations and...

Unlocking the Gaps to Improve SMA Outcomes

Spinal muscular atrophy (SMA) can be a debilitating condition causing immobility, respiratory difficulties, and reduced lifespan. But with the advent of new disease-modifying therapies, the prognosis for patients with SMA has been completely altered. These treatments may help patients live longer,...

Unveiling Anemia in Myelodysplastic Syndrome

Welcome to our interactive and engaging educational initiative on managing anemia in myelodysplastic syndromes (MDS). Anemia is a common issue in MDS, causing symptoms like fatigue, pallor, shortness of breath, and light-headedness. It can have a significant impact on patients' quality of life and...

Addressing the Challenges in Alzheimer’s Disease Diagnosis and Management

Alzheimer’s disease (AD) is the leading cause of cognitive impairment and dementia in older individuals (≥ 65 years) throughout the world. In the United States (U.S.), more than 6 million individuals carry this diagnosis, with many yet to be diagnosed. AD follows a prolonged, progressive disease...

Activating Clinicians to Deliver Effective Obesity Care

Approximately 70% of all adults in the United States are overweight or have obesity. Unfortunately, obesity remains underdiagnosed and inadequately addressed in routine practice. While enormous strides have been made in recent years relative to the safety and efficacy of anti-obesity medications...

Advanced Endometrial Cancer in the Immunotherapy Age

Endometrial cancer is among the few cancers increasing in incidence and mortality in the United State and remains the most common gynecologic cancer diagnosed. To improve clinical outcomes, clinicians treating patients with endometrial cancer need to understand the molecular classification of the...

Turning Complexity into Clarity in HAE Prophylaxis

Hereditary angioedema (HAE) is a rare but potentially life-threatening disease affecting approximately 1 in 67,000 individuals, with no identified differences in prevalence due to sex or ethnicity. The disease commonly presents with recurrent attacks of swelling in any part of the body. Given the...

Managing BRAF V600-mutant Colorectal Cancer

Colorectal cancer (CRC) continues to be the second most lethal cancer in the United States (US) with approximately 149,500 new cases and 52,980 deaths per year. Patients diagnosed at an advanced/metastatic stage have a five-year survival rate of roughly 14%. For these patients, initial treatment...

Oncology Innovations: Metastatic Non-Small Cell Lung Cancer

This interactive program updates learners on the latest guideline recommendations for biomarker identification and application in NSCLC. The program will enable learners to select appropriate personalized treatment pathways based on the tumor profile, while incorporating the latest scientific...

Multiple Myeloma Health Professional Needs Assessment Research Study

This research study explores the practices, beliefs, and priorities of health professionals treating Multiple Myeloma in order to identify key educational needs and interests. Through small, peer-led online groups, participating clinicians engage in self-assessments, a case-based group activity,...

Addressing the Complexities of MS Care during COVID

Since the beginning of the COVID-19 pandemic, there have been reservations regarding the risks of using immunosuppressive or immunomodulating agents to treat patients with multiple sclerosis (MS) in case these treatments increase infectious disease risk or reduce vaccine efficacy. Many MS patients...

New Directions in Atopic Dermatitis Management

Clinically heterogeneous presentation, with only intermittent symptoms and long latent periods for some patients, along with manifestations that overlap with other skin conditions make the diagnosis of atopic dermatitis difficult for clinicians, resulting in delays in diagnosis and treatment....

Improving the Care of Patients with Advanced Renal Cell Carcinoma

Renal cell carcinoma (RCC) remains the most common variety of renal cancer, representing 90% of the diagnoses. Within the United States (US), it is a relatively common malignant caner, ranking as sixth and tenth most common for men and women respectively. Yet, the incidence has been slowly but...

COPD Health Professional Needs Assessment Research Study

This research study will explore current and future practices, beliefs, and priorities of health professionals treating COPD in order to identify their educational needs and interests. The study is conducted in the setting of small, peer-led digital groups of clinicians who will be engaging in...

Turning Complexity into Clarity in Advanced Cervical Cancer

The current treatment of advanced, recurrent, and metastatic cervical cancer is difficult, especially as treatment progresses to the second line. Considerations for treatment are nuanced and numerous. Factors include prior treatments, treatment timing, and patient preference. The advent of...

Geographic Atrophy: What to Look For and When to Refer

This COPE-certified small group educational experience is designed for optometrists involved in the management of patients with geographic atrophy (GA). Key goals of the curriculum are: ~ Discuss the prevalence of age-related macular degeneration ~ Articulate the burden of illness linked to...

Turning Complexity into Clarity in AML

Acute myeloid leukemia (AML) continues to be the most common acute leukemia in adults, with an incidence of 5.5 cases per 100,000 persons annually. As such, more education is needed on key topics including use of induction therapy in the non-elderly population, treating suboptimal response to...

Treating Hepatitis C in the Primary Care Setting

This online, interactive curriculum will provide continuing education (CME/CE) for primary care providers (PCPs) to support their competence and confidence in treating patients with chronic hepatitis C virus (HCV) infection. Small-group workshops will utilize novel collaborative-education...

A Comprehensive Approach to Optimizing Glycemic Control

This CME/CE-certified activity has been developed with the aim of bringing together different members of the diabetes care team in small group virtual workshops that allow interactions through a variety of collaborative educational experiences. The goal of this education is to improve the use of...

Contemporary Approaches to Relapsed/Refractory Multiple Myeloma

The purpose of this curriculum is to improve the performance of learners to apply practice-changing clinical data and expert recommendations in order to optimize clinical outcomes with BCMA-targeted therapies for their patients with relapsed/refractory multiple myeloma. This will be achieved with...

Improving Beta-thalassemia Outcomes

With the increase in the lifespan of patients with beta thalassemia and demographic shifts in the U.S., hematologists are treating more patients with this condition. As such, more education is needed on key topics including disease fundamentals, transitioning patients to adult care, new and...

Modernizing Care of Patients with BCC: Changes in Management Approaches

This small group educational experience is designed for MDs, PA, RNs & NPs involved in the management of patients with basal cell carcinoma (BCC). Key goals of the curriculum are: • Identify patients for whom hedgehog inhibitor therapy may no longer be viable due to lack of response or adverse...

Improving Management of Advanced Non-Melanoma Skin Cancer

Improving Management of Advanced Non-Melanoma Skin Cancer is a comprehensive, evidence-based curriculum about the challenges in identifying patients at high risk for mBCC and la/mCSCC, screening methods and staging of these patients, and the new and emerging therapies for patients with NMSC. By...

Best Practices in Early-Stage NSCLC

This CE initiative will offer a roughly 4-week digital curriculum to interprofessional learners. The goal of the initiative is to establish meaningful, small group interactions between clinicians involved in the care of patients with early stage NSCLC that will, through a variety of collaborative...

Optimal Identification and Management of Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension (PAH) is a progressive disease and is associated with poor clinical outcomes. Data from the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) has shown that the diagnosis of PAH is often missed or delayed with the average length of time from...

Osteoarthritis and Pain: Intensive Training in Pain Management

Osteoarthritis and Pain: Intensive Training in Pain Management is a comprehensive evidence-based presentation about the burden of osteoarthritis (OA) and OA pain, the challenges of current pharmacologic and nonpharmacologic strategies, and evidence about the role of nerve growth factor in...